Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zuleika Michelini, Silvia Baroncelli, Alessandra Fantauzzi, Chiara Pasquale, Clementina Maria Galluzzo, Massimo Sanchez, Manuela Gatto, Roberta Amici, Marina Franco, Gabriella d’Ettorre, Caterina Fimiani, Ivano Mezzaroma, Vincenzo Vullo, Manuela Merli & Lucia Palmisano. (2016) Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis. HIV Clinical Trials 17:2, pages 49-54.
Read now
Read now
Articles from other publishers (26)
Tengjie Yu, Linlin Wu, Tingting Zhang, Hongyuan Hao, Jing Dong, Yexin Xu, Huizhu Yang, Huafang Liu, Lin Xie, Guangji Wang & Yan Liang. (2023) Insights into Q-markers and molecular mechanism of Sanguisorba saponins in treating ulcerative colitis based on lipid metabolism regulation. Phytomedicine 116, pages 154870.
Crossref
Crossref
Thangavelu Kokulnathan, Tzyy-Jiann Wang, Faheem Ahmed & Thamraa Alshahrani. (2023) Hydrothermal synthesis of ZnCr-LDH/Tungsten carbide composite: A disposable electrochemical strip for mesalazine analysis. Chemical Engineering Journal 451, pages 138884.
Crossref
Crossref
Zhiguo Li, Shan Zhang, Li Xu, Xuexun Fang, Youzhong Wan, Dahai Yu & Yi Guo. (2022) A tetrapeptide from maize combined with probiotics exerted strong anti-inflammatory effects and modulated gut microbiota in DSS-induced colitis mice. Food & Function 13:24, pages 12602-12618.
Crossref
Crossref
Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu & Hiroshi Nakase. (2022) Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis. Biomedicines 10:6, pages 1334.
Crossref
Crossref
Yufeng Zhang, Siu Kwan Wo, Wei Leng, Fang Gao, Xiaoyu Yan & Zhong Zuo. (2022) Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets. Journal of Controlled Release 346, pages 275-288.
Crossref
Crossref
Rong Li, Xue Huang, Lu Yang, Xiao Liang, Wenjun Huang, Keng Po Lai & Liming Zhou. (2022) Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis. Frontiers in Nutrition 9.
Crossref
Crossref
Giorgia Meineri, Elisa Martello, Elisabetta Radice, Natascia Bruni, Vittorio Saettone, David Atuahene, Angelo Armandi, Giulia Testa & Davide Giuseppe Ribaldone. (2022) Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives. Animals 12:7, pages 812.
Crossref
Crossref
Piotr Gadziński, Tomasz Zbigniew Osmałek, Anna Froelich, Oliwia Wilmańska, Agata Nowak & Adam Tatarek. (2022) Rheological and textural analysis as tools for investigation of drug-polymer and polymer–polymer interactions on the example of low-acyl gellan gum and mesalazine. Journal of Biomaterials Applications 36:8, pages 1400-1416.
Crossref
Crossref
Gaofeng Shi, Hui Jiang, Jianrong Feng, Xian Zheng, Dongjian Zhang, Cuihua Jiang & Jian Zhang. (2021) Aloe vera mitigates dextran sulfate sodium-induced rat ulcerative colitis by potentiating colon mucus barrier. Journal of Ethnopharmacology 279, pages 114108.
Crossref
Crossref
Brittany M. MillerAndreas J. Bäumler. (2021) The Habitat Filters of Microbiota-Nourishing Immunity. Annual Review of Immunology 39:1, pages 1-18.
Crossref
Crossref
Kun LiuBingjie JiaLiping Zhou, Lei XingLvying WuYuanyuan LiJungang Lu, Lei Zhang & Su Guan. (2020) Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model. Journal of Proteome Research 20:2, pages 1371-1381.
Crossref
Crossref
Yingjie Si, LanJun Shao, Shanqing Gao & Hongzhu Wen. (2021) Suppository treatment in ulcerative proctitis. European Journal of Inflammation 19, pages 205873922110151.
Crossref
Crossref
Ramesh C. Gupta, Robin B. Doss, Aryamitra Banerjee, Rajiv Lall, Ajay Srivastava & Anita Sinha. 2021. Nutraceuticals. Nutraceuticals
141
155
.
Heejung Park, Wooseong Kim, Dayoon Kim, Seongkeun Jeong & Yunjin Jung. (2019) Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug. Current Molecular Pharmacology 12:4, pages 272-280.
Crossref
Crossref
Huaying Fan, Zhenfang Gao, Kai Ji, Xin Li, Jingbao Wu, Yue Liu, Xuekai Wang, Haiyue Liang, Yanan Liu, Xiaoting Li, Pan Liu, Daquan Chen & Feng Zhao. (2019) The in vitro and in vivo anti-inflammatory effect of osthole, the major natural coumarin from Cnidium monnieri (L.) Cuss, via the blocking of the activation of the NF-κB and MAPK/p38 pathways. Phytomedicine 58, pages 152864.
Crossref
Crossref
Xin Zheng, Zhen Zhang, Botao Wang, Jiaxin Li, Chongyang Qiu, Qi Zhang & Ximo Wang. (2019) Efficacy and safety of once daily versus twice daily mesalazine for mild-to-moderate ulcerative colitis. Medicine 98:14, pages e15113.
Crossref
Crossref
Sophie E. Berends, Anne S. Strik, Mark Löwenberg, Geert R. D’Haens & Ron A. A. Mathôt. (2018) Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clinical Pharmacokinetics 58:1, pages 15-37.
Crossref
Crossref
Mariana X. Byndloss, Sandy R. Pernitzsch & Andreas J. Bäumler. (2018) Healthy hosts rule within: ecological forces shaping the gut microbiota. Mucosal Immunology 11:5, pages 1299-1305.
Crossref
Crossref
Zhang Dan, Wei Kai, Ma Xiaopeng, Wu Huangan, Hong Jue, Zhang Cuihong, Wu Lingxiang, Yan Huang, Liu Jie, Zhu Yi & Yang Ling. (2018) Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease. Journal of Traditional Chinese Medicine 38:2, pages 218-226.
Crossref
Crossref
Carmelo Scarpignato, Giovanni Barbara, Angel Lanas & Lisa L. Strate. (2018) Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therapeutic Advances in Gastroenterology 11, pages 175628481877130.
Crossref
Crossref
Masateru MiyakeMiki FujishimaDaisuke Nakai. (2017) Inhibitory Potency of Marketed Drugs for Ulcerative Colitis and Crohn’s Disease on PEPT1. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:9, pages 1572-1575.
Crossref
Crossref
Aryamitra Banerjee & Rajan Giri. 2016. Nutraceuticals. Nutraceuticals
109
122
.
Scott A. Strong. 2016. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery
807
817
.
Cord J. Andreas, Ying-Chen Chen, Constantinos Markopoulos, Christos Reppas & Jennifer Dressman. (2015) In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release. European Journal of Pharmaceutics and Biopharmaceutics 97, pages 39-50.
Crossref
Crossref
Erol R. Ağış, Berna Savaş & Mehmet Melli. (2015) Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis. Prostaglandins & Other Lipid Mediators 121, pages 63-69.
Crossref
Crossref
Shui-Jiao Chen, Xiao-Wei Liu, Jian-Ping Liu, Xi-Yan Yang & Fang-Gen Lu. (2014) Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World Journal of Gastroenterology 20:28, pages 9468-9475.
Crossref
Crossref